Critical illness model definitions have evolved from relatively straightforward descriptions of medical conditions and policy triggers to complex clinical phraseology better suited to medical grand rounds. As the product and the market continue to evolve, can CI retain its fundamental spirit and still remain sustainable? Dr. Philip Smalley believes it can.
Reprinted with permission from The Review, January 2011
